Results 1 to 10 of about 118,627 (256)
PharmaceuticalsBackground/Objectives: Asthma is a chronic inflammatory disorder of the airways affecting over 10% of the global population. It is characterized by airway inflammation, mucus hypersecretion, and bronchial hyperresponsiveness, driven predominantly by type
Miran Aswad +5 more
doaj +1 more source
An Evaluation of Regulatory Regimes of Medical Cannabis: What Lessons Can Be Learned for the UK?
Medical Cannabis and Cannabinoids, 2020 This paper evaluates current regulatory regimes of medical cannabis using peer-reviewed and grey literature as well as personal communications. Despite the legalization of medical cannabis in the UK in November 2018, patients still lack access
Anne Katrin Schlag
doaj +1 more source
Maltese health and social wellbeing student knowledge, attitudes and beliefs about medical cannabis
Complementary Therapies in Medicine, 2021 Given the recent emergence of medical cannabis legalization in Malta, the objective of this study was to assess knowledge, attitudes, and beliefs about medical cannabis among a sample of Maltese students. The sample comprised 327 students enrolled in the
Jamie Bonnici, Marilyn Clark
doaj +1 more source
Exploring medical cannabis use in individuals with a traumatic brain injury
Exploration of Medicine, 2023 Aim: Traumatic brain injury (TBI) is a common neurological condition, which can present with a wide range of neuropsychological symptoms. Treating this broad spectrum of symptoms represents a significant medical challenge.
Elizabeth N. R. Schjelderup +8 more
doaj +1 more source
Harm Reduction JournalBackground Medical cannabis use and public acceptance in the United States have increased over the past 25 years. However, access to medical cannabis remains limited, particularly for underserved populations. To understand how patients experience medical
Eloise W. Freitag +7 more
doaj +1 more source
BMC Nursing, 2019 Background In Canada, federal regulations allow Nurse Practitioners (NPs) to authorize medical cannabis. Nursing regulatory bodies, however, have been hesitant to include medical cannabis within NPs’ scope of practice.
Lynda G. Balneaves, Abeer A. Alraja
doaj +1 more source
Terpene-Enriched CBD oil for treating autism-derived symptoms unresponsive to pure CBD: Case report
Frontiers in Pharmacology, 2022 Cannabidiol (CBD) rich products are successfully used in some countries for treating symptoms associated with autism spectrum disorder (ASD). Yet, CBD provides insufficient intervention in some individuals, or for some characterizing symptoms of ASD ...
Noa Raz +5 more
doaj +1 more source
Preventive Medicine ReportsObjectives: We characterized trends in medical cannabis use; examined characteristics associated with medical cannabis use without medical authorization; and examined the association between recreational cannabis legalization and medical cannabis use in ...
Sameer Imtiaz +6 more
doaj +1 more source
A survey of the attitudes, beliefs and knowledge about medical cannabis among primary care providers
BMC Family Practice, 2019 Background Healthcare providers play a critical role in facilitating patient access to medical cannabis. However, previous surveys suggest only a minority of providers believe that medical cannabis confers benefits to patients.
Lindsey M. Philpot +2 more
doaj +1 more source
BMJ Open, 2021 Objective To explore values and preferences towards medical cannabis among people living with chronic pain.Design Mixed-methods systematic review.Data sources We searched MEDLINE, EMBASE and PsycINFO from inception to 17 March 2020.Study selection Pairs ...
Linan Zeng +10 more
doaj +1 more source